Document Detail


Sustained-release erythropoietin ameliorates cardiac function in infarcted rat-heart without inducing polycythemia.
MedLine Citation:
PMID:  17186991     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The usefulness of sustained-release erythropoietin for improving left ventricular (LV) function without polycythemia was evaluated in a rat chronic myocardial infarction model. METHODS AND RESULTS: Four weeks after left coronary artery ligation, 50 Sprague-Dawley rats were assigned to 5 groups (n=10, each). Control group had a gelatin sheet (20x20 mm) containing saline applied to the infarct area, whereas the 4 treatment groups had gelatin sheets incorporating erythropoietin 0.1 U, 1 U, 10 U and 100 U, respectively. Endpoint measurements performed at 8 weeks after the coronary ligation revealed that the fractional area change was larger for erythropoietin 1 U and 10 U than in the other 3 groups. The LV end-systolic elastance and the time constant of isovolumic relaxation were better for erythropoietin 1 U and 10 U than in the other 3 groups. The density of vessels larger than 50 microm in diameter was the highest in the erythropoietin 1 U group. The number of red blood cells was significantly increased in groups receiving erythropoietin 10 U and 100 U. CONCLUSIONS: Gelatin hydrogel sheets incorporating 1 U erythropoietin improved LV function without inducing polycythemia in a rat chronic myocardial infarction model.
Authors:
Xue Lin; Masatoshi Fujita; Naoki Kanemitsu; Yu Kimura; Keiichi Tambara; Goditha U Premaratne; Atsushi Nagasawa; Tadashi Ikeda; Yasuhiko Tabata; Masashi Komeda
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  Circulation journal : official journal of the Japanese Circulation Society     Volume:  71     ISSN:  1346-9843     ISO Abbreviation:  Circ. J.     Publication Date:  2007 Jan 
Date Detail:
Created Date:  2006-12-25     Completed Date:  2007-02-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101137683     Medline TA:  Circ J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  132-7     Citation Subset:  IM    
Affiliation:
Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Delayed-Action Preparations
Disease Models, Animal
Dose-Response Relationship, Drug
Echocardiography
Erythropoietin / administration & dosage,  pharmacology,  therapeutic use*
Gelatin
Heart / drug effects,  physiology*
Male
Myocardial Infarction / drug therapy*,  physiopathology
Neovascularization, Physiologic / drug effects
Polycythemia / physiopathology,  prevention & control*
Rats
Rats, Sprague-Dawley
Ventricular Dysfunction, Left / drug therapy,  physiopathology
Ventricular Remodeling / drug effects
Chemical
Reg. No./Substance:
0/Delayed-Action Preparations; 11096-26-7/Erythropoietin; 9000-70-8/Gelatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reverse perfusion-metabolism mismatch predicts good prognosis in patients undergoing cardiac resynch...
Next Document:  Granulocyte colony-stimulating factor prevents progression of monocrotaline-induced pulmonary arteri...